Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
Schrödinger

Schrödinger

New York, New York, USA

Schrödinger is an international scientific software and biotechnology company, founded in 1990, developing computational tools for drug discovery and materials science. Its physics-based platform, integrating AI and machine learning, accelerates the discovery of high-quality molecules and is used by top biopharma companies globally.

Hero image for Schrödinger
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in Schrödinger
Claim This Profile →

How We Help

Problem Statement

The company solves the problem of inefficient and lengthy traditional molecular discovery and design by transforming the process through a physics-based computational platform, aiming to accelerate the development of therapeutics and materials.

Core Technology

physics-based computational platform

Key Differentiators

accelerates drug discovery by enabling the rapid and accurate discovery of high-quality, novel molecules; reduces time and cost of bringing new drugs to market; works with all of the top 20 global biopharma companies

Clinical Focus

oncology programs

Target Customers

Global pharmaceutical companies (e.g., 19 of top 20), and collaboration partners for drug discovery.

Product Stage

Software platform is Mature/GA; Drug discovery programs are Concept/R&D (preclinical/clinical).

Company Info

Business Model
B2B (Software licensing) and a drug discovery model, advancing preclinical and clinical programs internally and through collaborations. SaaS is implied through platform licensing.
Founded
1990
Total Funding
394,200,000
Website
www.schrodinger.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

Computational toolsSoftwareAIMachine LearningDrug DiscoveryMaterials SciencePhysics-based computational platformmolecular discoverymolecular designmolecular modelingmachine learningartificial intelligenceMaestroGlideFEP+PrimeLiveDesignDesmond

Clinical & IP

🔬

Clinical Validation

Their platform is used by 19 of the top 20 global pharmaceutical companies, validating its utility. The company is also actively advancing preclinical and clinical drug discovery programs.

MedStartr Index Score

?
57

What do you think of Schrödinger?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Schrödinger